| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/29/2010 | US20100105034 Detecting and treating dementia |
| 04/29/2010 | US20100105033 Method for single nucleotide polymorphism and mutation detection using real time polymerase chain reaction microarray |
| 04/29/2010 | US20100105032 Highly sensitive multiplex single nucleotide polymorphism and mutation detection using real time ligase chain reaction microarray |
| 04/29/2010 | US20100105031 Method for prediction of the efficacy of vascularization inhibitor |
| 04/29/2010 | US20100105030 Nucleic acid base pairs |
| 04/29/2010 | US20100105029 Self-contained biological analysis |
| 04/29/2010 | US20100105028 Probe for detecting nucleic acids |
| 04/29/2010 | US20100105027 Detection of nucleic acids from multiple types of human papillomaviruses |
| 04/29/2010 | US20100105026 Optical measurement method for molecular detection using relaxation measurement in optically anisotropic nanoparticles and device for performing the method |
| 04/29/2010 | US20100105025 Devices for generating detectable polymers |
| 04/29/2010 | US20100105024 Rapid test including genetic sequence probe |
| 04/29/2010 | US20100105023 In Vitro Method Modeling The Consistency Generated In Vivo By Food During The Digestion Thereof |
| 04/29/2010 | US20100105022 Analyzing biological cell material based on different interactions between illumination light and cell components |
| 04/29/2010 | US20100105020 Quantitative measurement of glycated hemoglobin |
| 04/29/2010 | US20100104690 Tagged Microorganisms and Methods of Tagging |
| 04/29/2010 | US20100104597 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/29/2010 | US20100104594 Pathogen for bacterial poultry disease |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | US20100104584 Genes involved in mitochondrial biogenesis |
| 04/29/2010 | US20100104583 Gene Polymorphisms in VEGF and VEGF Receptor 2 as Markers for Cancer Therapy |
| 04/29/2010 | US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts |
| 04/29/2010 | US20100104581 Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions |
| 04/29/2010 | US20100104579 Trex1 as a marker for lupus erythematosus |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104555 HCV neutralizing epitopes |
| 04/29/2010 | US20100104549 Glufosfamide combination therapy |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | US20100104542 Cell transplantation |
| 04/29/2010 | US20100104541 Method for Preventing and Treating Cardiovascular Diseases with BRCA1 |
| 04/29/2010 | US20100104502 Compositions and methods for detecting and treating endothelial dysfunction |
| 04/29/2010 | US20100104501 Prss23 as a biomarker, therapeutic and diagnostic target |
| 04/29/2010 | CA2778603A1 Rapid and safe technique for performing pcr amplifications |
| 04/29/2010 | CA2750054A1 Transposon end compositions and methods for modifying nucleic acids |
| 04/29/2010 | CA2744886A1 Methods and systems for improved pharmaceutical intervention in coagulation control |
| 04/29/2010 | CA2741718A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 04/29/2010 | CA2741493A1 Cell culture kit, screening method, and method of manufacturing cell culture kit |
| 04/29/2010 | CA2741489A1 Methods, compositions, and kits for diagnosing, monitoring, and treating disease |
| 04/29/2010 | CA2741460A1 In vitro model of focal ischemia |
| 04/29/2010 | CA2741351A1 Diagnostic test for streptococcus equi |
| 04/29/2010 | CA2741331A1 Genetic markers for weight management and methods of use thereof |
| 04/29/2010 | CA2741190A1 High-throughput assay for evaluating dipeptidyl peptidase i activity |
| 04/29/2010 | CA2741114A1 Biomarkers for predicting the development of chronic autoimmune diseases |
| 04/29/2010 | CA2741087A1 Identification of signature genes associated with hepatocellular carcinoma |
| 04/29/2010 | CA2740923A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 04/29/2010 | CA2740913A1 Improved allele-specific amplification |
| 04/29/2010 | CA2740586A1 Methods and compositions for preventing artifacts in tissue samples |
| 04/29/2010 | CA2740351A1 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes |
| 04/29/2010 | CA2740241A1 Prostate stem cells and uses thereof |
| 04/29/2010 | CA2739886A1 Method for determining nucleic acids by real-time polymerase chain reaction and a device for the implementation thereof |
| 04/29/2010 | CA2738944A1 Biomarkers of mineralocorticoid receptor activation |
| 04/29/2010 | CA2738001A1 Determination of immunoglobulin encoding nucleid acid |
| 04/29/2010 | CA2734895A1 Receptor tyrosine kinase assays |
| 04/28/2010 | EP2180321A1 Semiconductor nanocrystal probes for biological applications |
| 04/28/2010 | EP2180313A1 Method and apparatus for detection of biomicromolecule |
| 04/28/2010 | EP2180309A2 Method and apparatus for synthesis of arrays of DNA probes |
| 04/28/2010 | EP2180307A2 Improved flow cytometer nozzle |
| 04/28/2010 | EP2180066A1 Single nucleotide polymorphism genotyping detection via the real-time invader assay microarray platform |
| 04/28/2010 | EP2180065A1 Method of reducing the molecular weight of at least one PCR product for its detection while maintaining its identity |
| 04/28/2010 | EP2180064A2 Multiplex quantification of nucleic acids in diseased cells |
| 04/28/2010 | EP2180063A1 Method of detecting target substance |
| 04/28/2010 | EP2180062A1 Method of detecting target substance |
| 04/28/2010 | EP2180051A2 Method for detecting and quantifying endogenous wheat DNA sequence |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
| 04/28/2010 | EP2179744A1 Decreasing potential latrogenic risks associated with influenza vaccines |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179643A2 Method of producing double low restorer lines of Brassica napus having a good agronomic value |
| 04/28/2010 | EP2179291A2 Drug selection for lung cancer therapy using antibody-based arrays |
| 04/28/2010 | EP2179290A2 Analyte detection assays |
| 04/28/2010 | EP2179286A2 Trim24 (tif1a) as p53 modulator and cancer target |
| 04/28/2010 | EP2179278A1 Electrochemical biosensor measuring system |
| 04/28/2010 | EP2179064A1 Method for identification of novel anaerobic denitrifying bacteria utilizing petroleum components as sole carbon source |
| 04/28/2010 | EP2179063A1 Application of anaerobic denitrifying bacteria utilizing petroleum components as sole carbon source for oil recovery |
| 04/28/2010 | EP2179062A2 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 04/28/2010 | EP2179061A2 Toll like receptor modulators |
| 04/28/2010 | EP2179060A2 Differential expression of micrornas in nonfailing versus failing human hearts |
| 04/28/2010 | EP2179059A1 Ovine identification method |
| 04/28/2010 | EP2179058A2 Predictive marker for egfr inhibitor treatment |
| 04/28/2010 | EP2179057A1 Predictive marker for egfr inhibitor treatment |
| 04/28/2010 | EP2179056A2 Egfr inhibitor treatment marker |
| 04/28/2010 | EP2179055A1 Predictive marker for egfr inhibitor treatment |
| 04/28/2010 | EP2179053A2 Determination of the activity of proteases |
| 04/28/2010 | EP2179052A2 Detection of micro-organisms based on their nad-dependent dna ligase activity |
| 04/28/2010 | EP2179051A1 A method for detecting biofuel producing microbes |
| 04/28/2010 | EP2179041A2 Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis |
| 04/28/2010 | EP2179040A2 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 04/28/2010 | EP2179037A2 Methods for diagnosis, prognosis and methods of treatment |
| 04/28/2010 | EP2179027A1 Electrochemical test strip |
| 04/28/2010 | EP2179025A2 Intergrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
| 04/28/2010 | EP2178897A1 Nucleic acid sequences for the amplification and detection of respiratory viruses |
| 04/28/2010 | EP2178532A2 Anti-bacterial drug targeting of genome maintenance interfaces |
| 04/28/2010 | EP2178359A2 Plants with increased resistance to diabrotica virgifera and ostrinia nubilalis |
| 04/28/2010 | EP2178357A2 Methods to identify soybean aphid resistant quantitative trait loci in soybean and compositions thereof |
| 04/28/2010 | EP1831404B1 Optoelectronic detection system |
| 04/28/2010 | EP1778867B1 Methods and compositions to detect nucleic acids in a biological sample |
| 04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 04/28/2010 | EP1668160B1 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 04/28/2010 | EP1664332B1 Kinase and phosphatase assays |
| 04/28/2010 | EP1618208B1 Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome |